Does a dialysis session for fluid removal without dialysate filtration eliminate Lyrica (pregabalin) from the body?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dialysis for Fluid Removal Only Does Not Eliminate Lyrica (Pregabalin)

A dialysis session for fluid removal only (ultrafiltration without dialysate filtration) does not significantly eliminate Lyrica (pregabalin) from the body. While pregabalin is highly dialyzable during standard hemodialysis with dialysate, ultrafiltration alone lacks the diffusive clearance mechanism needed to remove this medication.

Pharmacokinetics of Pregabalin and Dialysis Mechanisms

  • Pregabalin is primarily eliminated unchanged by the kidneys with a mean elimination half-life of 6.3 hours in patients with normal renal function 1, 2
  • Pregabalin has pharmacokinetic properties that make it highly dialyzable during standard hemodialysis:
    • Low molecular weight (159.23 Da)
    • Low volume of distribution (approximately 0.5 L/kg)
    • Minimal protein binding (<2%)
    • Minimal metabolism (>90% excreted unchanged in urine) 1, 3
  • During standard hemodialysis with dialysate, pregabalin concentrations are reduced by approximately 50% after a 4-hour session 1

Ultrafiltration vs. Standard Hemodialysis

  • Ultrafiltration (fluid removal only) works primarily through hydrostatic pressure to remove excess fluid across a semipermeable membrane 4
  • Standard hemodialysis removes solutes through diffusion across concentration gradients between blood and dialysate 4
  • Without dialysate exchange, the diffusive clearance mechanism necessary for removing medications like pregabalin is absent 4
  • Isolated ultrafiltration sessions are sometimes added to standard treatment regimens specifically for fluid management, not for solute removal 4

Clinical Implications

  • Patients receiving pregabalin who undergo fluid-only removal sessions will maintain therapeutic (or potentially toxic) levels of the medication 5, 3
  • For patients with renal impairment requiring pregabalin:
    • Dose adjustments are necessary based on creatinine clearance 1, 5
    • Supplemental doses may be required after standard hemodialysis sessions (with dialysate) to maintain therapeutic levels 1, 5
  • In cases of pregabalin toxicity, standard hemodialysis (not isolated ultrafiltration) has been shown effective for drug removal with clearance rates of approximately 88.8 mL/min 3

Common Pitfalls and Considerations

  • Don't confuse ultrafiltration-only sessions with standard hemodialysis when considering medication clearance 4
  • Be aware that pregabalin doses may need adjustment in patients with renal impairment, with approximately 50% reduction for each 50% decrease in creatinine clearance 1, 5
  • Monitor for signs of pregabalin toxicity (myoclonus, altered mental status) in dialysis patients, especially those receiving isolated ultrafiltration who may accumulate the drug 3, 6
  • Similar to pregabalin, other medications primarily eliminated by the kidneys (like gabapentin) also require standard hemodialysis with dialysate for significant removal 7

In summary, while pregabalin is effectively removed by standard hemodialysis with dialysate filtration, a dialysis session for fluid removal only will not significantly eliminate pregabalin from the body.

References

Research

Treatment of pregabalin toxicity by hemodialysis in a patient with kidney failure.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2009

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Disposition of gabapentin in anuric subjects on hemodialysis.

Journal of clinical pharmacology, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.